JNK/SAPK activity contributes to TRAIL-induced apoptosis

Cell Death and Differentiation

Volumn 6, Issue 2, 1999, Pages 130-135

  Herr, Ingrid ^a   Wilhelm, Dagmar ^a,b   Meyer, Eric ^a,c   Jeremias, Irmela ^a   Angel, Peter ^a   Debatin, Klaus Michael ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; CD95 L (APO1 L Fas L); JNKK MKK4; TRAIL (APO2 L)

Indexed keywords

CASPASE; CASPASE INHIBITOR; FAS ANTIGEN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL LINE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033040818     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400467     Document Type: Article

References (39)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Davis T, Rauch C, Smith CA and Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271: 12687-12690
3. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J and Dixit VM (1997) The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113
4. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Godard AD, Godowski P and Ashkenazi A (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-820
5. Walczak H, Degli-Esposti MA, Johnson RS, Snolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG and Rauch CT (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16: 5386-5397
6. Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA and Goodwin RG (1998) The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7: 813-820
7. Emery JG, McDonnell P, Brigham Burke M, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC and Young PR (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273: 14363-14367
8. Schneider P, Thome M, Burns K, Bodmer J-L, Hofmann K, Kataoka T, Holler N and Tschopp J (1998) TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7: 831-836
9. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J and Hood L (1998) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7: 821-830
10. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
11. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer P, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95/Fas/APO-1 death-inducing signaling complex. Cell 85: 817-827
12. Boldin MP, Goncharov TM, Goltsev YV and Wallach D (1996) Involvement of MACH, a novel MORT/FADD-interacting protease, in Fas/APO-1-and TNF-receptor-induced cell death. Cell 85: 803-815
13. Mariani SM, Matiba B, Armandola EA and Krammer PH (1997) Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell. Biol. 137: 221-229
14. Jeremias I, Herr I, Bochler T and Debatin K-M (1998) TRAIL/APO-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28: 143-152
15. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS and Spiegel S (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800-803
16. Tepper CF, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, Hannun YA and Seldin MF (1995) Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92: 8443-8447
17. Fraser A and Evan G (1996) A license to kill. Cell 89: 1067-1076
18. Susin SA, Zamzami N, Castedo M, Daugas E, Wang H-G, Geley S, Fassy F, Reed JC and Kroemer G (1997) The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/ CD95-and ceramide-induced apoptosis. J. Exp. Med. 186: 25-37
19. Cahill MA, Peter ME, Kischkel FC, Chinnaiyan AM, Dixit VM, Krammer PH and Nordheim A (1996) CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 13: 2087-2096
20. Wilson JW, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA and Budd RC (1996) JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 26: 989-994
21. Latinis KM, Carr LL, Peterson EJ, Norian LA, Eliason SLand Koretzky GA (1997) Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158: 4602-4611
22. Verheij M, Bose R, Hua Lin X, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN (1996) Requirement for ceramide initiated JNK/SAPK signalling in stress-induced apoptosis. Nature 380: 75-79
23. Liu Z-G, Hsu H, Goeddel DV and Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565-576
24. Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C and Levrero M (1997) Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203
25. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E and Sanchez I (1994) Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA 94: 3302-3307
26. Yang X, Khosravi-Far R, Chang HY and Baltimore D (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067-1076
27. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794-2804
28. Wilhelm D, Bender K, Knebel A and Angel P (1997) The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including JNK/SAPKs and p38 kinase by alkylating agents. Mol. Cell. Biol. 17: 4792-4800
29. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett, Avruch J, Kyriakis JM and Zon LI (1994) Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372: 794-798
30. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331
31. Wajant H, Johannes FJ, Haas E, Siemienski K, Schwenzer R, Schubert G, Weiss T, Grell M and Scheurich P (1998) Dominant-negative FADD inhibits TNFR60-, Fas/APO1-and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr. Biol. 8: 113-116
32. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Tagaki M, Matsumoto K, Miyazono K and Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94
33. Chang HY, Nishitoh H, Yang X, Ichijo H and Baltimore D (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 18: 1860-1863
34. Nishina H, Fischer KD, Radvanyl L, Shahinian A, Hakem R, Rubie EA, Bernstein A, Mak TW, Woodgett JR and Penninger JM (1997) Stress-signalling protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385: 350-353
35. Park J, Kim I, Young JO, Lee K-W, Man P-L and Choi E-J (1997) Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of bcl-2. J. Biol. Chem. 272: 16725-16728
36. Herr I, Wilhelm D, Bochler T, Angel P and Debatin K-M (1997) Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16: 6200-6208
37. Herr I, Wilhelm D, Bochler T, Angel Pand Debatin K-M (1998) JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-α. Int. J. Cancer, in press
38. Dhein J, Walczak H, Bumler C, Debatin K-M and Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373: 438-441
39. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME and Dixit VM (1996) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271: 4961-4965